Suppr超能文献

氧化应激生物标志物作为轻度认知障碍的临床前标志物:年龄和性别的影响

Oxidative Stress Biomarkers as Preclinical Markers of Mild Cognitive Impairment: The Impact of Age and Sex.

作者信息

Ioannidou Stavroula, Tsolaki Magda, Ginoudis Argyrios, Tamvakis Androniki, Tsolaki Anthoula, Makedou Kali, Lymperaki Evgenia

机构信息

Department of Biomedical Sciences, International Hellenic University, 57400 Thessaloniki, Greece.

Greek Association of Alzheimer's Disease and Related Disorders (GAADRD), 54248 Thessaloniki, Greece.

出版信息

J Pers Med. 2025 Apr 26;15(5):171. doi: 10.3390/jpm15050171.

Abstract

Reactive oxygen species (ROS) are involved in the pathophysiology of neurodegeneration and cognitive decline, indicating the potential use of oxidative stress biomarkers for early diagnosis. Mild cognitive impairment (MCI) is defined as a cognitive decline beyond normal aging, without significant impact on daily functioning, and is considered an important stage of early detection of neurodegeneration. This study aimed to investigate serum and cerebrospinal fluid (CSF) levels of oxidative stress biomarkers, total ROS and malondialdehyde (MDA) in patients with MCI to evaluate their utility in the early diagnosis of Alzheimer's disease (AD). Levels of oxidative stress biomarkers were also assessed according to age and sex, as well as their correlation with the established CSF biomarkers, including amyloid-beta (Aβ40, Aβ42 and Aβ42/Aβ40 ratio), phosphorylated tau protein (p-tau) and total tau (t-tau). A total of 114 adults were divided into three groups: MCI (A-) patients with a normal CSF Aβ42/Aβ40 ratio ( = 38), MCI (A+) patients with an abnormal Aβ42/Aβ40 ratio ( = 38) and healthy cognitive function individuals with a normal Aβ42/Aβ40 ratio ( = 38). Established CSF biomarkers were conducted using an automated immunochemical method, while total ROS levels were measured by fluorometry and MDA levels were determined by competitive inhibition enzyme immunoassay. A statistically significant difference was observed in CSF MDA levels ( < 0.05) and serum ROS levels ( < 0.05) between the study groups. Sex analysis revealed significantly higher levels of CSF MDA levels in the MCI (A+) males' group ( < 0.05). In terms of age categorization, serum MDA levels were markedly higher in the MCI (A+) group of older patients ( < 0.01). These findings highlight the importance of individualized approaches, including investigation of oxidative stress biomarkers profile to prevent and manage individuals in the early stages of MCI, considering demographic factors.

摘要

活性氧(ROS)参与神经退行性变和认知衰退的病理生理过程,这表明氧化应激生物标志物在早期诊断方面具有潜在用途。轻度认知障碍(MCI)被定义为超出正常衰老的认知衰退,对日常功能没有显著影响,并且被认为是神经退行性变早期检测的一个重要阶段。本研究旨在调查MCI患者血清和脑脊液(CSF)中氧化应激生物标志物、总ROS和丙二醛(MDA)的水平,以评估它们在阿尔茨海默病(AD)早期诊断中的效用。还根据年龄和性别评估了氧化应激生物标志物的水平,以及它们与已确立的CSF生物标志物的相关性,这些标志物包括淀粉样β蛋白(Aβ40、Aβ42和Aβ42/Aβ40比值)、磷酸化tau蛋白(p-tau)和总tau蛋白(t-tau)。共有114名成年人被分为三组:CSF中Aβ42/Aβ40比值正常的MCI(A-)患者(n = 38)、Aβ42/Aβ40比值异常的MCI(A+)患者(n = 38)和Aβ42/Aβ40比值正常且认知功能正常的个体(n = 38)。使用自动免疫化学方法检测已确立的CSF生物标志物,通过荧光法测量总ROS水平,采用竞争性抑制酶免疫测定法测定MDA水平。研究组之间在CSF中MDA水平(P < 0.05)和血清ROS水平(P < 0.05)方面观察到统计学上的显著差异。性别分析显示,MCI(A+)男性组的CSF中MDA水平显著更高(P < 0.05)。在年龄分类方面,老年MCI(A+)组的血清MDA水平明显更高(P < 0.01)。这些发现突出了个体化方法的重要性,包括考虑人口统计学因素,对氧化应激生物标志物谱进行调查,以在MCI早期阶段预防和管理个体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8214/12113603/3a81542d1fba/jpm-15-00171-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验